Information  X 
Enter a valid email address
  Print          More announcements

Friday 11 June, 2021

JPMorgan Sec.Plc

UDG Healthcare Plc 38.5a amend

RNS Number : 7027B
JPMorgan Securities Plc
11 June 2021
 

Ap24

 

  AMENDMENT

FORM   38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

J.P. Morgan Securities Plc

Companydealtin

UDG Healthcare Plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

€0.05 ordinary shares

Date of dealing

25 May 2021

 

2.  DEALINGS  (Note   2)

 

(a)  Purchases and sales

 

Total numberofrelevantsecuritiesacquired

Highestpricepaid (Note 3)

Lowest price paid

(Note 3)

328,104

10.7169 GBP

10.5700 GBP

 

 

Total numberofsecuritiesdisposed

Highestpricereceived (Note 3)

Lowestpricereceived

(Note 3)

174,348

10.7300 GBP

10.5800 GBP

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 4)

Numberofrelevantsecurities

(Note 5)

Priceperunit

(Note 3)

Equity Swap

Decrease Long

 

 

 

 

 

 

 

 

 

 

Decrease Short

 

 

 

 

 

Increase Long

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase Short

 

 

 

 

 

 

Opening a Long Position

 

 

Opening a Short Position

 

485

49,448

3,693

484

1,758

154

397

5,940

4,876

2,844

 

2,229

3,700

5,556

200

4,156

 

3,895

44,956

5,888

130

1,493

4

716

6,278

16,282

10,704

2,239

918

205

 

15,000

40,308

2,368

2,468

205

2,249

 

1,704

798

 

2,502

135,000

10.5861 GBP

10.5900 GBP

10.5902 GBP

10.5905 GBP

10.6039 GBP

10.6101 GBP

10.6203 GBP

10.6306 GBP

10.6315 GBP

10.6352 GBP

 

10.5977 GBP

10.5978 GBP

10.6233 GBP

10.6800 GBP

10.7275 GBP

 

10.5900 GBP

10.5904 GBP

10.6166 GBP

10.6175 GBP

10.6183 GBP

10.6200 GBP

10.6238 GBP

10.6268 GBP

10.6325 GBP

10.6386 GBP

10.6387 GBP

10.6425 GBP

10.6882 GBP

 

10.5969 GBP

10.6029 GBP

10.6302 GBP

10.6319 GBP

10.6702 GBP

10.6831 GBP

 

10.6106 GBP

10.6170 GBP

 

10.6013 GBP

10.6334 GBP

 

Ap25

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varyingetc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, Europeanetc.

Expiry date

Option money paid/received perunit (Note 3)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 3)

 

 

 

 

 

3.   OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities
under any option referred to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any derivative referred
to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

Dateofdisclosure

11 June 2021

Contactname

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

UDG Healthcare Plc

Nature of connection (Note 6)

Financial adviser to CD&R Fund XI

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEBLGDLDGBDGBB

a d v e r t i s e m e n t